FDC LIMITED·PHARMACEUTICALS 70.24·Pharmaceuticals & Biotechnology Companies

Price

348.6

-0.45%
O:351
H:353
L:347
C:348.6

52W Range

312.95527.8
+11%/-34%

Market Cap

₹5,675.56 Cr

Traded: ₹3.39 Cr (0.06%) 0.0x

Free Float: ₹1,284.38 Cr (0.26% of FF traded)

Volume · 60D trend

96.9 K 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:-15% 3M:-10% 6M:-3% 12M:-17%

Valuation

P/E19.4
P/B2.3
P/S2.6
EV/EBIT22.9

Business Strength

ROE12.2%
ROCE16.4%
OPM15.9%
NPM12.9%

Growth (3Y CAGR)

EPS+5.5%
Sales+7.0%
Profit+16.0%
3Y Return+1.0%

Balance Sheet

Debt/Equity0.0
Debt0.03 Cr
Pledge0.0%
CWIP/Fixed Asset9.6%

Cash Position

CFO/NP71.2%
FCF40.4 Cr
FCF 3Y Avg418 Cr
Cash/MCap1.0%

Others

Div Yield1.0%
Div Payout29.0%
Cash Conv. Cycle102 days
Tradeable Free Float22.6%

MTF Exposure Trend

60 sessions · funded amount, % of FF, daily delta

Current
₹ 29.69 Cr
2.31% FF
60d high
₹ 33.55 Cr
60d low
₹ 24.25 Cr
60d mean
₹ 29.38 Cr
vs mean
▲ 1.05%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
Sales
+8.0%
+10.0%
+7.0%
--
+3.0%
Decelerating
ROE
+13.0%
+12.0%
+13.0%
--
--
Stable
Return
+8.0%
+1.0%
+1.0%
-19.0%
--
Stable
Profit
+6.0%
+1.0%
+16.0%
--
+14.0%
Stable

Quarterly Results

Jun 2026

5 Aug
Rev
668 Cr
+3% YoY+14% QoQ
OPM21.0%
NPM19.8%
PAT
--132 Cr
EPS
+9% YoY8.1

Mar 2026

27 May
Rev
585 Cr
+19% YoY+26% QoQ
OPM18.0%
NPM17.6%
PAT
+167% YoY103 Cr
EPS
+167% YoY6.3

Dec 2025

5 Feb
Rev
465 Cr
+0% YoY-2% QoQ
OPM11.0%
NPM6.0%
PAT
+18% YoY28 Cr
EPS
-24% YoY1.7

Sep 2025

PDF
Rev
473 Cr
-8% YoY-27% QoQ
OPM7.0%
NPM5.9%
PAT
-61% YoY28 Cr
EPS
-61% YoY1.7

Jun 2025

PDF
Rev
648 Cr
+2% YoY+32% QoQ
OPM22.0%
NPM18.7%
PAT
+2% YoY121 Cr
EPS
+2% YoY7.5

Mar 2025

PDF
Rev
492 Cr
+6% YoY+6% QoQ
OPM11.0%
NPM7.9%
PAT
-16% YoY39 Cr
EPS
-16% YoY2.4

Dec 2024

PDF
Rev
464 Cr
+1% YoY-10% QoQ
OPM10.0%
NPM8.0%
PAT
-53% YoY37 Cr
EPS
-53% YoY2.3

Sep 2024

PDF
Rev
514 Cr
+6% YoY-19% QoQ
OPM14.0%
NPM14.0%
PAT
+3% YoY72 Cr
EPS
+3% YoY4.4

Jun 2024

PDF
Rev
638 Cr
+19% YoY+38% QoQ
OPM23.0%
NPM18.6%
PAT
+8% YoY119 Cr
EPS
+10% YoY7.3

Mar 2024

PDF
Rev
462 Cr
+6% YoY+1% QoQ
OPM12.0%
NPM10.0%
PAT
+51% YoY46 Cr
EPS
+54% YoY2.8

Dec 2023

PDF
Rev
458 Cr
+12% YoY-6% QoQ
OPM18.0%
NPM17.3%
PAT
+94% YoY79 Cr
EPS
+98% YoY4.9

Sep 2023

PDF
Rev
486 Cr
+9% YoY-9% QoQ
OPM16.0%
NPM14.4%
PAT
+35% YoY70 Cr
EPS
+38% YoY4.3

Jun 2023

PDF
Rev
536 Cr
--+23% QoQ
OPM23.0%
NPM20.5%
PAT
+55% YoY110 Cr
EPS
--6.6

Mar 2023

Rev
435 Cr
--+6% QoQ
OPM11.0%
NPM7.1%
PAT
+194% YoY31 Cr
EPS
--1.9

Dec 2022

Rev
409 Cr
---8% QoQ
OPM12.0%
NPM10.0%
PAT
+14% YoY41 Cr
EPS
--2.5

Sep 2022

Rev
445 Cr
----
OPM15.0%
NPM11.7%
PAT
-28% YoY52 Cr
EPS
--3.1

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.01
Interest Coverage6.5x
Promoter Pledge0.0%
Borrowings15 Cr

Efficiency

Receivable Days26 days
Inventory Days182 days
Payable Days106 days
Cash Conversion cycle102 days

Cash Position

Operating Cash Flow200 Cr
Investing Cash Flow-110 Cr
Financing Cash Flow-93 Cr
Free Cash Flow40 Cr

Detailed Financials

Jun 2026PDF ↗
Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Jun 2025PDF ↗
Mar 2025PDF ↗
Dec 2024PDF ↗
Sep 2024PDF ↗
Jun 2024PDF ↗
Mar 2024PDF ↗
Dec 2023PDF ↗
Sep 2023PDF ↗
Jun 2023PDF ↗
Mar 2023
Dec 2022
Sep 2022
Sales668585465473648492464514638462458486536435409445
Expenses525478412439508438417444492406374410414386360378
Operating Profit1431065234140544770147568476122494967
OPM %21.0%18.0%11.0%7.0%22.0%11.0%10.0%14.0%23.0%12.0%18.0%16.0%23.0%11.0%12.0%15.0%
Other Income485002136161935282025272971813
Interest1211111111111111
Depreciation15141515151613141110101010101010
Profit Before Tax1751403638160535190163659893141455769
Tax %24.0%26.0%22.0%26.0%24.0%27.0%28.0%20.0%27.0%29.0%19.0%25.0%22.0%32.0%28.0%25.0%
Net Profit1321032828121393772119467970110314152
Exceptional Items--0-21000000000000--
EPS (Rs)8.16.31.71.77.52.42.34.47.32.84.94.36.61.92.53.1
Sales Growth (YoY)3.1%18.9%0.2%-8.0%1.6%6.5%1.3%5.8%19.0%6.2%12.0%9.2%--------
Sales Growth (QoQ)14.2%25.8%-1.7%-27.0%31.7%6.0%-9.7%-19.4%38.1%0.9%-5.8%-9.3%23.2%6.4%-8.1%--
OP Growth (YoY)2.1%96.3%10.6%-51.4%-4.8%-3.6%-44.0%-7.9%20.5%14.3%71.4%13.4%--------
OP Growth (QoQ)34.9%103.8%52.9%-75.7%159.3%14.9%-32.9%-52.4%162.5%-33.3%10.5%-37.7%149.0%0.0%-26.9%--
Profit Growth (YoY)--167.0%18.0%-61.0%2.0%-16.0%-53.0%3.0%8.0%51.0%94.0%35.0%55.0%194.0%14.2%-28.0%
EPS Growth (YoY)9.3%166.8%-23.7%-60.6%1.9%-16.2%-53.2%3.0%10.4%53.5%98.0%37.5%--------
EPS Growth (QoQ)28.2%264.9%0.0%-76.6%213.0%4.4%-48.4%-39.5%157.4%-41.7%13.5%-35.2%257.8%-24.8%-21.1%--
OP Margin21.4%18.1%11.2%7.2%21.6%11.0%10.1%13.6%23.0%12.1%18.3%15.6%22.8%11.3%12.0%15.1%
Net Margin19.8%17.6%6.0%5.9%18.7%7.9%8.0%14.0%18.6%10.0%17.3%14.4%20.5%7.1%10.0%11.7%
Material Cost %--35.2%32.6%30.6%32.3%32.8%34.7%35.6%36.2%33.2%32.9%34.8%34.0%35.4%37.4%36.3%
Employee Cost %--18.7%25.8%25.5%20.4%24.7%25.6%24.3%18.4%22.3%22.6%20.6%19.8%22.8%23.3%22.0%
P/S2.593.023.372.80------------------------
P/E19.4023.3032.2725.75------------------------
P/B2.282.702.882.39------------------------

Shareholding Pattern

Shareholders:55.0K (-3.5%)
Current MixJun 2026

Exchange Filings

50
Company Update13 Aug 2026

This is to inform you that the company''s Subsidiary, FDC International Ltd., has received Marketing Authorisation from the MHRA, UK, for Atropine 1.0% w/v Eye Drops, Solution.

Result05 Aug 2026

Financial Results for the quarter ended June 30, 2026

Board Meeting05 Aug 2026

Outcome for the Board Meeting Held on 5th August, 2026.

Company Update27 Jul 2026

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026

Board Meeting23 Jul 2026

FDC Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting to be held ....

Insider Trading / SAST29 Jun 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sandhya Mohan Chandavarkar Trust (through its ....

Insider Trading / SAST29 Jun 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nandan Mohan Chandavarkar & PACs

Insider Trading / SAST29 Jun 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mohan Anand Chandavarkar Trust (through its ....

Insider Trading / SAST26 Jun 2026

Trading Window of the Company shall remain closed for all the Designated persons, Connected persons and their relative(s) with effect from July 01, 2026, till 48 hours after the declaration ....

Company Update28 May 2026

This is with regards to our intimation made on May 27, 2026 for Press Release wherein there was typographical error in the Subject line of Press Release in the mentioned year, which shall ....

AGM/EGM28 May 2026

Please find attached the scrutinizer report for Postal Ballot

Company Update28 May 2026

Annual Secretarial Compliance report of FDC Limited for Financial year ending March 31, 2026.

AGM/EGM28 May 2026

Please find attached the outcome of Postal Ballot

Board Meeting27 May 2026

Board meeting outcome for approval of the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2026.

Result27 May 2026

Approved Standalone and consolidated financial results for the financial year ending March 31, 2026

Company Update27 May 2026

Press release on Q4, FY 2026-27 and 12 months, FY 2026-27 results

Company Update18 May 2026

Announcement under Regulation 30 - ANDA approval

Board Meeting18 May 2026

FDC Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting to be held ....

AGM/EGM13 May 2026

Newspaper publication - Corrigendum in respect of Postal Ballot Notice dated 21st April, 2026

Company Update13 May 2026

Information regarding the Notice of the opening of a special window for re-lodgment of the transfer requests of physical shares and for claiming of unclaimed dividend under the " Saksham ....

AGM/EGM09 May 2026

Corrigendum to Postal Ballot Notice dated April 21, 2026

Company Update24 Apr 2026

Copies of Newspaper advertisement regarding the Notice of Postal Ballot.

Company Update24 Apr 2026

Confirmation regarding Company not falling under Large Corporate criteria as on March 31, 2026

AGM/EGM22 Apr 2026

Intimation of Postal Ballot Notice

Company Update21 Apr 2026

This is to inform you that the Board of Directors have approved seeking Shareholder''s approval through Postal Ballot with regard to appointment of Mr. Kishore Saletore as an Independent Director.

Company Update10 Apr 2026

Please find attached Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.

Insider Trading / SAST26 Mar 2026

Intimation of Closure of trading window

Company Update20 Mar 2026

General update

Company Update18 Mar 2026

Please find attached Announcement under Regulation 30( LODR), 2015 Pertaining to Change in Directorate.

Company Update20 Feb 2026

The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi C Bhanot & Virgo Advisors Pvt Ltd

Insider Trading / SAST20 Feb 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virgo Advisors Pvt Ltd

Insider Trading / SAST20 Feb 2026

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi C Bhanot

Insider Trading / SAST20 Feb 2026

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi C Bharot

Insider Trading / SAST20 Feb 2026

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....

Company Update17 Feb 2026

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Company Update10 Feb 2026

Disclosure under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015

Corp. Action05 Feb 2026

PFA the Record Date intimation

Corp. Action05 Feb 2026

We hereby inform that the Board meeting held on February 05, 2026 has approved an Interim Dividend of Rs. 5/- per Equity Share of face value of Rs. 1/- each for financial year 2025-26.

Company Update05 Feb 2026

Press Release for unaudited financial results for Quarter and Nine months ended December 31, 2025.

Board Meeting05 Feb 2026

We hereby inform that the Board meeting held on February 05, 2026 has inter alia approved the unaudited (standalone and consolidated ) financial results for Quarter and Nine Months ended ....

Board Meeting30 Jan 2026

FDC Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve Update on board meeting - Consideration ....

Board Meeting29 Jan 2026

FDC Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve unaudited standalone and consolidated financial ....

AGM/EGM28 Jan 2026

Please find attached scrutinizer''s report for Postal Ballot.

AGM/EGM28 Jan 2026

Please find attached outcome of the Postal Ballot.

Company Update09 Jan 2026

Announcement under Regulation 30 (LODR) - ANDA approval

Company Update08 Jan 2026

Please find attached certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.

Company Update29 Dec 2025

Intimation under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015

Company Update26 Dec 2025

Copies of the newspaper advertisement regarding the Notice of Postal Ballot.

Insider Trading / SAST24 Dec 2025

Intimation of Closure of Trading Window

AGM/EGM24 Dec 2025

Intimation of Postal Ballot notice

Annual Reports

14

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

Concalls

11

Nov 2023

30 Nov 2023

Feb 2023

28 Feb 2023

Nov 2022

30 Nov 2022

Nov 2022

30 Nov 2022

Aug 2022

31 Aug 2022

May 2022

31 May 2022

Feb 2022

28 Feb 2022

Dec 2021

31 Dec 2021

Jun 2017

30 Jun 2017

Nov 2016

30 Nov 2016

May 2016

31 May 2016

Held by ETFs

1 ETFs hold fdc · sorted by weight

#ETFWeight %
1

MOHEALTH

MOTILALAMC - MOHEALTH

0.12%

Held by Mutual Funds

11 schemes hold fdc · sorted by weight

#SchemeWeight %
1

ICICI Prudential ESG Exclusionary Strategy Fund

ICICI Prudential Mutual Fund

2.08%
2

ICICI Prudential Smallcap Fund

ICICI Prudential Mutual Fund

0.78%
3

ICICI Prudential Retirement Fund

ICICI Prudential Mutual Fund

0.54%
4

Nippon India Small Cap Fund

Nippon India Mutual Fund

0.23%
5

ICICI Prudential Bharat Consumption Fund

ICICI Prudential Mutual Fund

0.22%
6

Bandhan BSE Healthcare Index Fund

Bandhan Mutual Fund

0.13%
7

ICICI Prudential MNC Fund

ICICI Prudential Mutual Fund

1.17%
8

Bandhan Small Cap Fund

IDFC Mutual Fund

0.07%
9

Titanium Equity Long-Short Fund

Tata Mutual Fund

1.46%
10

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

ICICI Prudential Mutual Fund

0.78%
11

Motilal Oswal BSE 1000 Index Fund

Motilal Oswal Mutual Fund

0.01%